- Home
- CMPS vs GDEN Comparison
CMPS vs GDEN Comparison
Compare CMPS & GDEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMPS | GDEN |
|---|---|---|
| Founded | 2020 | N/A |
| Country | United Kingdom | United States |
| Employees | N/A | 504 |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 732.6M | 763.2M |
| IPO Year | 2020 | 1998 |
Fundamental Metrics
Financial Performance| Metric | CMPS | GDEN |
|---|---|---|
| Price | $7.61 | $28.93 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 5 |
| Target Price | $18.71 | ★ $32.25 |
| AVG Volume (30 Days) | ★ 3.6M | 236.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.43% |
| EPS Growth | ★ 0.86 | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $666,818,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.94 |
| P/E Ratio | ★ N/A | $324.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.25 | $19.57 |
| 52 Week High | $8.90 | $32.74 |
Technical Indicators
Market Signals| Indicator | CMPS | GDEN |
|---|---|---|
| Relative Strength Index (RSI) | 60.11 | 63.78 |
| Support Level | $5.95 | $28.73 |
| Resistance Level | $8.55 | $29.72 |
| Average True Range (ATR) | 0.56 | 0.41 |
| MACD | 0.17 | 0.11 |
| Stochastic Oscillator | 69.40 | 74.13 |
Price Performance
Historical ComparisonAbout CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.